Cargando…

Vectored vaccines to protect against PRRSV

PRRSV is the causative agent of the most important infectious disease affecting swine herds worldwide, producing great economic losses. Commercially available vaccines are only partially effective in protection against PRRSV. Moreover, modified live vaccines may allow virus shedding, and could rever...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz, Jazmina L.G., Zúñiga, Sonia, Bécares, Martina, Sola, Isabel, Ceriani, Juan E., Juanola, Sandra, Plana, Juan, Enjuanes, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114413/ https://www.ncbi.nlm.nih.gov/pubmed/20600388 http://dx.doi.org/10.1016/j.virusres.2010.06.017

Ejemplares similares

Coronavirus Gene 7 Counteracts Host Defenses and Modulates Virus Virulence
por: Cruz, Jazmina L. G., et al.
Publicado: (2011)

Role of RNA chaperones in virus replication
por: Zúñiga, Sonia, et al.
Publicado: (2009)

Antigenic structures stably expressed by recombinant TGEV-derived vectors
por: Becares, Martina, et al.
Publicado: (2014)

Coronavirus reverse genetic systems: Infectious clones and replicons
por: Almazán, Fernando, et al.
Publicado: (2014)

Reprint of: Coronavirus reverse genetic systems: Infectious clones and replicons()
por: Almazán, Fernando, et al.
Publicado: (2014)

Coronavirus nucleocapsid protein is an RNA chaperone
por: Zúñiga, Sonia, et al.
Publicado: (2007)

Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence
por: Ortego, Javier, et al.
Publicado: (2003)

Transmissible gastroenteritis virus (TGEV)-based vectors with engineered murine tropism express the rotavirus VP7 protein and immunize mice against rotavirus
por: Ribes, Juan Manuel, et al.
Publicado: (2011)

Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway
por: Ortego, Javier, et al.
Publicado: (2007)

Recombinant Chimeric Transmissible Gastroenteritis Virus (TGEV)—Porcine Epidemic Diarrhea Virus (PEDV) Virus Provides Protection against Virulent PEDV
por: Pascual-Iglesias, Alejandro, et al.
Publicado: (2019)

MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity
por: Wang, Li, et al.
Publicado: (2021)

Virulence factors in porcine coronaviruses and vaccine design
por: Zuñiga, Sonia, et al.
Publicado: (2016)

Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection
por: Gutiérrez-Álvarez, Javier, et al.
Publicado: (2021)

Coronavirus Reverse Genetics and Development of Vectors for Gene Expression
por: Enjuanes, L., et al.
Publicado: (2005)

Biochemical Aspects of Coronavirus Replication
por: Enjuanes, Luis, et al.
Publicado: (2006)

Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation
por: Han, Kiwon, et al.
Publicado: (2014)

Regulation of Coronavirus Transcription: Viral and Cellular Proteins Interacting with Transcription-Regulating Sequences
por: Zúñiga, Sonia, et al.
Publicado: (2006)

Protection provided by a commercial modified-live porcine reproductive and respiratory syndrome virus (PRRSV) 1 vaccine (PRRSV1-MLV) against a Japanese PRRSV2 field strain
por: Miranda, Joel, et al.
Publicado: (2023)

RNA-RNA and RNA-protein interactions in coronavirus replication and transcription
por: Sola, Isabel, et al.
Publicado: (2011)

Minimum Determinants of Transmissible Gastroenteritis Virus Enteric Tropism Are Located in the N-Terminus of Spike Protein
por: Sanchez, Carlos M., et al.
Publicado: (2019)

Evaluation of the Cross-Protective Efficacy of a Chimeric PRRSV Vaccine against Two Genetically Diverse PRRSV2 Field Strains in a Reproductive Model
por: Jeong, Chang-Gi, et al.
Publicado: (2021)

A porcine reproductive and respiratory syndrome virus (PRRSV)-specific IgM as a novel adjuvant for an inactivated PRRSV vaccine improves protection efficiency and enhances cell-mediated immunity against heterologous PRRSV challenge
por: Chen, Rui, et al.
Publicado: (2022)

Gene expression, virulence and vaccine development in coronaviruses
por: Enjuanes, Luis, et al.
Publicado: (2008)

Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2
por: Madapong, Adthakorn, et al.
Publicado: (2020)

Comparative evaluation of 4 commercial modified‐live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous dual Korean PRRSV‐1 and PRRSV‐2 challenge
por: Oh, Taehwan, et al.
Publicado: (2020)

Improved Vaccine against PRRSV: Current Progress and Future Perspective
por: Nan, Yuchen, et al.
Publicado: (2017)

PRRSV Vaccine Strain-Induced Secretion of Extracellular ISG15 Stimulates Porcine Alveolar Macrophage Antiviral Response against PRRSV
por: Liu, Hongbin, et al.
Publicado: (2020)

Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology
por: Morales, Lucía, et al.
Publicado: (2022)

Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
por: Almazán, Fernando, et al.
Publicado: (2013)

Systemic CD4 cytotoxic T cells improve protection against PRRSV-1 transplacental infection
por: Li, Yanli, et al.
Publicado: (2023)

Efficacy of a live attenuated highly pathogenic PRRSV vaccine against a NADC30-like strain challenge: implications for ADE of PRRSV
por: Chen, Xin-xin, et al.
Publicado: (2021)

Systemic Homologous Neutralizing Antibodies Are Inadequate for the Evaluation of Vaccine Protective Efficacy against Coinfection by High Virulent PEDV and PRRSV
por: Qiu, Ming, et al.
Publicado: (2022)

Xanthohumol inhibits PRRSV proliferation and alleviates oxidative stress induced by PRRSV via the Nrf2–HMOX1 axis
por: Liu, Xuewei, et al.
Publicado: (2019)

Ginsenoside Rg1 Suppresses Type 2 PRRSV Infection via NF-κB Signaling Pathway In Vitro, and Provides Partial Protection against HP-PRRSV in Piglet
por: Yu, Zhi-qing, et al.
Publicado: (2019)

Follow-Up of PRRSv-Vaccinated Piglets Born from PRRSv-Vaccinated, ELISA-Seropositive and ELISA-Seronegative Sows
por: Fiers, Jorian, et al.
Publicado: (2023)

Efficacy of Type 2 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against the 2010 isolate of Vietnamese highly pathogenic PRRSV challenge in pigs
por: ISEKI, Hiroshi, et al.
Publicado: (2017)

A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
por: Zhang, Zhigang, et al.
Publicado: (2021)

Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories
por: Malicoat, Johnny, et al.
Publicado: (2022)

The structural biology of PRRSV
por: Dokland, Terje
Publicado: (2010)

Cellular Innate Immunity against PRRSV and Swine Influenza Viruses
por: Crisci, Elisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r3k747q5dcq72lep5njsit9rkq